NADPH oxidase 1 is a novel pharmacological target for the development of an antiplatelet drug without bleeding side effects
- Submitting institution
-
The University of Bath
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 215045204
- Type
- D - Journal article
- DOI
-
10.1096/fj.202001086RRR
- Title of journal
- FASEB Journal
- Article number
- -
- First page
- 13969
- Volume
- 34
- Issue
- 10
- ISSN
- 0892-6638
- Open access status
- Compliant
- Month of publication
- August
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
https://faseb.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1096%2Ffj.202001086RRR&file=fsb220964-sup-0004-Supinfo.docx
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
10
- Research group(s)
-
A - Drug & Target Discovery
- Citation count
- 1
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
